urothelium

(redirected from urothelial)

ur·o·the·li·um

(yūr'ō-thē'lē-ŭm),
The epithelial lining of the urinary tract.
[uro- + epithelium]

ur·o·the·li·um

(yūr'ō-thē'lē-ŭm)
The epithelial lining of the urinary tract.
The epithelial lining of the urinary tract.
References in periodicals archive ?
Immunohistochemistry to enhance progenic allocation and guide decision-making of patients with advanced urothelial cancer receiving first-line chemotherapy.
The aim of this study was to investigate the prognostic value of pretreatment NLR in a large cohort of Chinese patients with upper tract urothelial carcinoma (UTUC).
Micropapillary variant of urothelial carcinoma (UC) of the bladder is an aggressive tumour, comprising 0.6-6% of all UC.
ENPNewswire-August 14, 2019--Basilea starts phase 1/2 study with derazantinib in urothelial cancer
Food and Drug Administration for the investigational agent enfortumab vedotin for the treatment of patients with locally advanced or metastatic urothelial cancer who have received a PD-1/L1 inhibitor and who have received a platinum-containing chemotherapy in the neoadjuvant/adjuvant, locally advanced or metastatic setting.
M2 PHARMA-July 17, 2019-Seattle Genetics and Astellas Submit Biologics License Application to FDA for Enfortumab Vedotin for Patients with Locally Advanced or Metastatic Urothelial Cancer
Seattle Genetics (SGEN) and Astellas Pharma (ALPMY) announced submission of a biologics license application for accelerated approval to the FDA for the investigational agent enfortumab vedotin for the treatment of patients with locally advanced or metastatic urothelial cancer who have received a PD-1/L1 inhibitor and who have received a platinum-containing chemotherapy in the neoadjuvant/adjuvant, locally advanced or metastatic setting.
Urothelial tumours are rare in children and should be excluded in young patients who present with painless haematuria.
Chapter 2 of the 4th edition of the World Health Organization (WHO) Classification of Tumors of the Urinary System and Male Genital Organs (2016) (1) provides a contemporary review of urothelial neoplasms, including their multiple morphologic variants and diverse genomic landscape.
M2 EQUITYBITES-April 15, 2019-Janssen Pharmaceutical Companies wins US FDA accelerated approval for BALVERSA (erdafitinib) to treat urothelial carcinoma
Global Banking News-April 15, 2019-Janssen Pharmaceutical Companies wins US FDA accelerated approval for BALVERSA (erdafitinib) to treat urothelial carcinoma
It boasts 98-100% sensitivity for urinary tract stones (1) and 89-100% sensitivity for detection of urothelial carcinoma (UC).